GlassScriptPhysician profile
David James Culpepper
NPI 1386021079
$4,714.68
in general payments reported to CMS, 2019-2025
7 companies · $2,271 in 2025
The $2,271 reported for 2025 was more than what 89% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2022: $143 · 2023: $1,033 · 2024: $1,075 · 2025: $2,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,687 · Education: $493 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,686.94 |
| Education | $492.96 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $2,651.86 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $961.63 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $668.67 | 2023-2025 | Sunosi |
| Inspire Medical Systems, INC. | $182.15 | 2025 | Inspire |
| 3b Medical, INC. | $164.93 | 2023-2025 | Luna |
| Takeda Pharmaceuticals U.S.A., INC. | $47.07 | 2025 | |
| Depuy Synthes Sales INC. | $38.37 | 2025 | Cerepak Uniform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Culpepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.